MedPath

The Effects of Flaxseed Supplement on Weight and Biochemical Factors in Overweight and Obese Subject

Phase 2
Completed
Conditions
Overweight and Obesity
Interventions
Dietary Supplement: Placebo
Dietary Supplement: flaxseed
Behavioral: Exercise recommendation
Registration Number
NCT02410668
Lead Sponsor
National Nutrition and Food Technology Institute
Brief Summary

To study the effects of Flaxseed supplement on weight, lipid profile and inflammatory factors in subjects with over weight and obesity, 50 patients will be randomly allocated to receive placebo or 30 grams milled Flaxseed for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, weight, waist and hip circumference, lipid profile and some inflammatory markers will be assessed and compared between groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Age of 18 to 70 years
  • Body Mass Index (BMI) between 25-40
Exclusion Criteria
  • diabetes mellitus
  • cardiovascular diseases and cancers
  • major systemic diseases
  • gastrointestinal problems
  • liver and renal failure
  • history of allergy or high consumption of nuts, flaxseed, or sesame seeds
  • weight loss within the past 6 mo of >5% of body weight or current adherence to a weight-reduction diet
  • pregnancy, lactation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FlaxseedExercise recommendation30 grams Flaxseed powder combine with dietary and exercise recommendation
controlExercise recommendationdietary and exercise recommendation
controlPlacebodietary and exercise recommendation
Flaxseedflaxseed30 grams Flaxseed powder combine with dietary and exercise recommendation
Primary Outcome Measures
NameTimeMethod
weight12 weeks
waist and hip circumference12 weeks
Secondary Outcome Measures
NameTimeMethod
lipid profile12 weeks
© Copyright 2025. All Rights Reserved by MedPath